The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
The Challenge of HIV-1 Subtype Diversity
Open accessAbstract
HIV-1 has evolved multiple mechanisms to elude immune control. The view of virus as classifiable into distinct subtypes needs to reflect the reality of the constant emergence of new strains. This review discusses the implications of subtype diversity in HIV-1 for possible differential rates of disease progression, responses to antiretroviral therapy (including the development of resistance), and vaccine development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M., & Ho, D. D. (1996) · Science · doi:10.1126/science.271.5255.1582 · Cited by 3,531
Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1
Quinn, T. C., Wawer, M. J., Sewankambo, N., Serwadda, D., Li, C., Wabwire-Mangen, F., Meehan, M. O., Lutalo, T., & Gray, R. H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421303 · Cited by 3,020
Timing the ancestor of the HIV-1 pandemic strains.
Korber, B., Muldoon, M., Theiler, J., Gao, F., Gupta, R., Lapedes, A., Hahn, B. H., Wolinsky, S., & Bhattacharya, T. (2000) · Science · doi:10.1126/science.288.5472.1789 · Cited by 1,021
Kaslow, R. A., Carrington, M., Apple, R., Park, L., Muñoz, A., Saah, A. J., Goedert, J. J., Winkler, C., O'Brien, S. J., Rinaldo, C., et al. (1996) · Nature Medicine · doi:10.1038/nm0496-405 · Cited by 970
Chimpanzee Reservoirs of Pandemic and Nonpandemic HIV-1
Keele, B. F., Van Heuverswyn, F., Li, Y., Bailes, E., Takehisa, J., Santiago, M. L., Bibollet-Ruche, F., Chen, Y., Wain, L. V., Liegeois, F., et al. (2006) · Science · doi:10.1126/science.1126531 · Cited by 957
The rgp120 HIV Vaccine Study Group (2005) · The Journal of Infectious Diseases · doi:10.1086/428404 · Cited by 952
Kwong, P. D., Doyle, M. L., Casper, D. J., Cicala, C., Leavitt, S. A., Majeed, S., Steenbeke, T. D., Venturi, M., Chaiken, I., Fung, M., et al. (2002) · Nature · doi:10.1038/nature01188 · Cited by 889
Barouch, D. H., Santra, S., Schmitz, J. E., Kuroda, M. J., Fu, T.-M., Wagner, W., Bilska, M., Craiu, A., Zheng, X. X., Krivulka, G. R., et al. (2000) · Science · doi:10.1126/science.290.5491.486 · Cited by 881
Pitisuttithum, P., Gilbert, P., Gurwith, M., Heyward, W., Martin, M., van Griensven, F., Hu, D., Tappero, J. W., Choopanya, K., & Bangkok Vaccine Evaluation Group (2006) · The Journal of Infectious Diseases · doi:10.1086/508748 · Cited by 847
A new classification for HIV-1
Berger, E. A., Doms, R. W., Fenyö, E.-M., Korber, B. T. M., Littman, D. R., Moore, J. P., Sattentau, Q. J., Schuitemaker, H., Sodroski, J., & Weiss, R. A. (1998) · Nature · doi:10.1038/34571 · Cited by 830
An African HIV-1 sequence from 1959 and implications for the origin of the epidemic
Zhu, T., Korber, B. T., Nahmias, A. J., Hooper, E., Sharp, P. M., & Ho, D. D. (1998) · Nature · doi:10.1038/35400 · Cited by 637
Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004
Hemelaar, J., Gouws, E., Ghys, P. D., & Osmanov, S. (2006) · AIDS · doi:10.1097/01.aids.0000247564.73009.bc · Cited by 629
Kuiken, C., Foley, B., Freed, E., Hahn, B., Marx, P., McCutchan, F., Mellors, J., Wolinsky, S., & Korber, B. (2002) · doi:10.2172/1184349 · Cited by 570
Self-citationRobertson, D. L., Sharp, P. M., McCutchan, F. E., & Hahn, B. H. (1995) · Nature · doi:10.1038/374124b0 · Cited by 562
Self-citationEvolution and transmission of stable CTL escape mutations in HIV infection
Goulder, P. J. R., Brander, C., Tang, Y., Tremblay, C., Colbert, R. A., Addo, M. M., Rosenberg, E. S., Nguyen, T., Allen, R., Trocha, A., et al. (2001) · Nature · doi:10.1038/35085576 · Cited by 543
SIV infection in wild gorillas
Van Heuverswyn, F., Li, Y., Neel, C., Bailes, E., Keele, B. F., Liu, W., Loul, S., Butel, C., Liegeois, F., Bienvenue, Y., et al. (2006) · Nature · doi:10.1038/444164a · Cited by 409
Gao, F., Robertson, D. L., Morrison, S. G., Hui, H., Craig, S., Decker, J., Fultz, P. N., Girard, M., Shaw, G. M., Hahn, B. H., et al. (1996) · Journal of Virology · doi:10.1128/jvi.70.10.7013-7029.1996 · Cited by 358
Frost, S. D. W., Wrin, T., Smith, D. M., Pond, S. L. K., Liu, Y., Paxinos, E., Chappey, C., Galovich, J., Beauchaine, J., Petropoulos, C. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504658102 · Cited by 353
Westby, M., Smith-Burchnell, C., Mori, J., Lewis, M., Mosley, M., Stockdale, M., Dorr, P., Ciaramella, G., & Perros, M. (2007) · Journal of Virology · doi:10.1128/jvi.02006-06 · Cited by 350
Catanzaro, A. T., Koup, R. A., Roederer, M., Bailer, R. T., Enama, M. E., Moodie, Z., Gu, L., Martin, J. E., Novik, L., Chakrabarti, B. K., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/509258 · Cited by 321
Sagar, M., Wu, X., Lee, S., & Overbaugh, J. (2006) · Journal of Virology · doi:10.1128/jvi.00141-06 · Cited by 308
Piyasirisilp, S., McCutchan, F. E., Carr, J. K., Sanders-Buell, E., Liu, W., Chen, J., Wagner, R., Wolf, H., Shao, Y., Lai, S., et al. (2000) · Journal of Virology · doi:10.1128/jvi.74.23.11286-11295.2000 · Cited by 296
Self-citationDesign and Pre-Clinical Evaluation of a Universal HIV-1 Vaccine
Létourneau, S., Im, E.-J., Mashishi, T., Brereton, C., Bridgeman, A., Yang, H., Dorrell, L., Dong, T., Korber, B., McMichael, A. J., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000984 · Cited by 281
Kiwanuka, N., Laeyendecker, O., Robb, M., Kigozi, G., Arroyo, M., McCutchan, F., Eller, L. A., Eller, M., Makumbi, F., Birx, D., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/527416 · Cited by 264
Self-citationAn HIV Vaccine — Evolving Concepts
Johnston, M. I., & Fauci, A. S. (2007) · New England Journal of Medicine · doi:10.1056/nejmra066267 · Cited by 257
Carr, J. K., Salminen, M. O., Koch, C., Gotte, D., Artenstein, A. W., Hegerich, P. A., St Louis, D., Burke, D. S., & McCutchan, F. E. (1996) · Journal of Virology · doi:10.1128/jvi.70.9.5935-5943.1996 · Cited by 251
Self-citationGenetic Variants of HIV-1 in Thailand
McCUTCHAN, F. E., HEGERICH, P. A., BRENNAN, T. P., PHANUPHAK, P., SINGHARAJ, P., JUGSUDEE, A., BERMAN, P. W., GRAY, A. M., FOWLER, A. K., & BURKE, D. S. (1992) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1992.8.1887 · Cited by 250
Self-citationHIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture
Brenner, B. G., Oliveira, M., Doualla-Bell, F., Moisi, D. D., Ntemgwa, M., Frankel, F., Essex, M., & Wainberg, M. A. (2006) · AIDS · doi:10.1097/01.aids.0000232228.88511.0b · Cited by 226
Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 DNA Candidate Vaccine
Graham, B. S., Koup, R. A., Roederer, M., Bailer, R. T., Enama, M. E., Moodie, Z., Martin, J. E., McCluskey, M. M., Chakrabarti, B. K., Lamoreaux, L., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/509259 · Cited by 223
Cilliers, T., Nhlapo, J., Coetzer, M., Orlovic, D., Ketas, T., Olson, W. C., Moore, J. P., Trkola, A., & Morris, L. (2003) · Journal of Virology · doi:10.1128/jvi.77.7.4449-4456.2003 · Cited by 201
A review of vaccine research and development: The human immunodeficiency virus (HIV)☆
GIRARD, M., OSMANOV, S., & KIENY, M. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.02.031 · Cited by 174
Huang, W., Eshleman, S. H., Toma, J., Fransen, S., Stawiski, E., Paxinos, E. E., Whitcomb, J. M., Young, A. M., Donnell, D., Mmiro, F., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00218-07 · Cited by 172
Blackard, J. T., Cohen, D. E., & Mayer, K. H. (2002) · Clinical Infectious Diseases · doi:10.1086/339547 · Cited by 169
The Rational Design of an AIDS Vaccine
Douek, D. C., Kwong, P. D., & Nabel, G. J. (2006) · Cell · doi:10.1016/j.cell.2006.02.005 · Cited by 166
Tang, J., Tang, S. W., Lobashevsky, E. S., Myracle, A. D., Fideli, U., Aldrovandi, G. M., Allen, S. A., Musonda, R. M., & Kaslow, R. A. (2002) · Journal of Virology · doi:10.1128/jvi.76.16.8276-8284.2002 · Cited by 145
Similar rate of disease progression among individuals infected with HIV-1 genetic subtypes A-D
Alaeus, A., Lidman, K., Björkman, A., et al. (1999) · AIDS · doi:10.1097/00002030-199905280-00005 · Cited by 117
Njai, H. F., Gali, Y., Vanham, G., Clybergh, C., Jennes, W., Vidal, N., Butel, C., Mpoudi-Ngollé, E., Peeters, M., & Ariën, K. K. (2006) · Retrovirology · doi:10.1186/1742-4690-3-40 · Cited by 116
Doualla‐Bell, F., Avalos, A., BRENNER, B. G., Gaolathe, T., Mine, M., Gaseitsiwe, S., Oliveira, M., Moisi, D., Ndwapi, N., Moffat, H., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00714-06 · Cited by 113
HIV Vaccines: New Frontiers in Vaccine Development
Duerr, A. C., Wasserheit, J. N., & Corey, L. (2006) · Clinical Infectious Diseases · doi:10.1086/505979 · Cited by 112
Viral load differences in early infection with two HIV-1 subtypes
Hu, D. J., Vanichseni, S., Mastro, T. D., et al. (2001) · AIDS · doi:10.1097/00002030-200104130-00003 · Cited by 110
Hudgens, M. G., Longini, I. M., Vanichseni, S., Hu, D. J., Kitayaporn, D., Mock, P. A., Halloran, M. E., Satten, G. A., Choopanya, K., & Mastro, T. D. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.2.159 · Cited by 104
Did Merck's Failed HIV Vaccine Cause Harm?
Cohen, J. (2007) · Science · doi:10.1126/science.318.5853.1048 · Cited by 98
Grossman, Z., Vardinon, N., Chemtob, D., Alkan, M. L., Bentwich, Z., Burke, M., Gottesman, G., Istomin, V., Levi, I., Maayan, S. L., et al. (2001) · AIDS · doi:10.1097/00002030-200108170-00001 · Cited by 93
Pillay, D., Walker, A. S., Gibb, D. M., Rossi, A. D., Kaye, S., Ait‐Khaled, M., Muñoz‐Fernández, M. Á., Babiker, A. G., & Paediatric European Network for Treatment of AIDS (PENTA) (2002) · The Journal of Infectious Diseases · doi:10.1086/342680 · Cited by 91
Weaver, E. A., Lu, Z., Camacho, Z. T., Moukdar, F., Liao, H., Ma, B.-J., Muldoon, M. R., Theiler, J. P., Nabel, G. J., Letvin, N. L., et al. (2006) · Journal of Virology · doi:10.1128/jvi.02484-05 · Cited by 78
Palma, A. C., Araújo, F., Duque, V., Borges, F., Paixão, M. T., & Camacho, R. J. (2007) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2007.01.009 · Cited by 77
Kijak, G. H., Tovanabutra, S., Sanders‐Buell, E., et al. (2006) · Virology · doi:10.1016/j.virol.2006.07.055 · Cited by 47
Placebocontrolled Phase 3 Trial of a Recombinant Glycoprotein 120 Vaccine to Prevent HIV-1 Infection
Sydman, D. R. (2006) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70372-9 · Cited by 32
Cited by
Origins of HIV and the AIDS Pandemic
Sharp, P. M., & Hahn, B. H. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006841 · Cited by 1,496
“Although the initial distribution of these subtypes and CRFs may have been largely caused by chance events, recent studies have suggested that viruses of different subtypes vary in their biological properties, which may influence their epidemiology (Taylor et al. 2008).”
BackgroundInfluentialHIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
McElrath, M. J., De Rosa, S. C., Moodie, Z., Dubey, S., Kierstead, L., Janes, H., Defawe, O. D., Carter, D. K., Hural, J., Akondy, R., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61592-5 · Cited by 713
The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic
Broder, S. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.10.002 · Cited by 520
Broadly Neutralizing Antiviral Antibodies
Corti, D., & Lanzavecchia, A. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095916 · Cited by 475
Volz, E. M., Koelle, K., & Bedford, T. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002947 · Cited by 417
Metadata
- Authors
- Taylor, B. S., Sobieszczyk, M. E., McCutchan, F. E., & Hammer, S. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-04-10
- Volume
- 358
- Issue
- 15
- Pages
- 1590-1602
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1989468850
- Cited by
- 635
- References
- 48
- FWCI
- 19.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.